Skip to main content
Equibles

SPHERA FUNDS MANAGEMENT LTD.

Position in TENX — Tenax Therapeutics, Inc.

CIK 1496201 TEL AVIV, L3
Back to TENX Full portfolio

Position in TENX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,748,910
-$425,969 QoQ
Shares Held
120,200
-11.6% QoQ
Ownership
0.321%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#51
of 111 holders
Holding Since
Sep 2024
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TENX Over Time

Shares Held

Position Value (USD)

Derivatives in TENX

reported options exposure · as of Jun 30, 2026
CallValue
$1,856,580
CallShares
127,600
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SPHERA FUNDS MANAGEMENT LTD. holds $446,002,188 across 71 Biotechnology names. TENX ranks #58 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MLYS
Mineralys Therapeutics, Inc.
 1,469,971 $39,659,817
2 SNDX
Syndax Pharmaceuticals Inc
 1,014,606 $22,179,287
3 RARE
Ultragenyx Pharmaceutical Inc.
 588,494 $19,649,814
4 BMRN
Biomarin Pharmaceutical Inc
 328,550 $18,799,631
5 CYTK
Cytokinetics Inc
 219,987 $18,740,692
6 BBIO
BridgeBio Pharma, Inc.
 245,346 $18,273,370
7 COGT
Cogent Biosciences, Inc.
 459,340 $17,776,458
8 INSM
INSMED Inc
 118,800 $12,666,456

All Filings in TENX

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,748,910 120,200
2026-06-30 $1,856,580 127,600
2026-03-31 $2,174,879 136,015
2025-12-31 $2,317,453 190,111
2024-09-30 $100,914 29,166